Tilray Brands’ subsidiary, Tilray Medical, has launched Redecan-branded medical cannabis in Australia. The subsidiary is ...

Shares of Tilray Brands Inc. TLRY slid 1.11% to $1.78 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 2.51% to ...

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.80, representing a -0.55% change from its previous close.

Shares of Tilray Brands Inc. TLRY sank 0.55% to $1.80 Wednesday, on what proved to be an all-around rough trading session for ...

Cannabis stock Tilray ($TSE:TLRY) is making moves worldwide, and one of its latest comes from its subsidiary, Tilray Medical.

Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “The launch of Redecan, a premium cannabis brand, in Australia is another significant milestone for Tilray ...

In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $1.81, indicating a +0.56% shift from the previous trading day.

Tilray Brands agreed to acquire from DDH a promissory note for $23.8 million payable by 1974568 Ontario Limited.

Tilray Brands, Inc. TLRY has concluded the acquisition of Atwater Brewery from Molson Coors Beverage Company TAP. This marks ...

NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has ...

Tilray Brands, Inc. (TLRY) closed the latest trading day at $1.70, indicating no change from the previous session's end. This change lagged the S&P 500's daily gain of 0.45%. Meanwhile, the Dow lost 0 ...

Shares of cannabis providers soared in intraday trading Monday after former President Donald Trump said he wanted to ease ...